The burden of non-alcoholic fatty liver disease (NAFLD) is growing in people with HIV. NAFLD is associated with obesity, however it can occur in normoweight (lean) patients. We aimed to investigate lean NAFLD in HIV-infected patients
ObjectivesHuman immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may increase...
BACKGROUND AND AIMS: To promote our understanding of the relative contribution of metabolic and vira...
Background and Aims. To promote our understanding of the relative contribution of metabolic and vira...
Background. The burden of nonalcoholic fatty liver disease (NAFLD) is growing in people living with ...
Non-alcoholic fatty liver disease (NAFLD) occurs among persons without chronic viral hepatitis or si...
BACKGROUND: The prevalence and predictors of nonalcoholic fatty liver disease (NAFLD) in human immun...
Background: The prevalence and factors associated with nonalcoholic fatty liver disease (NAFLD) are ...
Introduction: The burden of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatiti...
BACKGROUND: The prevalence and factors associated with nonalcoholic fatty liver disease (NAFLD) are ...
: Despite the decreasing total incidence of liver-related deaths, liver disease remains one of the m...
Cardiovascular and liver disease are main contributors to mortality in people with HIV (PWH). In HIV...
The burden of liver-related morbidity remains high among HIV-infected patients, despite advances in ...
Liver disease is an important cause of morbidity and mortality in people living with HIV (PLWH), of ...
Background: Nonalcoholic hepatic steatosis/non- alcoholic fatty liver disease (NAFLD) is rapidly bec...
Introduction. Chronic liver disease (CLD) is becoming a major cause of mortality in patients who are...
ObjectivesHuman immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may increase...
BACKGROUND AND AIMS: To promote our understanding of the relative contribution of metabolic and vira...
Background and Aims. To promote our understanding of the relative contribution of metabolic and vira...
Background. The burden of nonalcoholic fatty liver disease (NAFLD) is growing in people living with ...
Non-alcoholic fatty liver disease (NAFLD) occurs among persons without chronic viral hepatitis or si...
BACKGROUND: The prevalence and predictors of nonalcoholic fatty liver disease (NAFLD) in human immun...
Background: The prevalence and factors associated with nonalcoholic fatty liver disease (NAFLD) are ...
Introduction: The burden of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatiti...
BACKGROUND: The prevalence and factors associated with nonalcoholic fatty liver disease (NAFLD) are ...
: Despite the decreasing total incidence of liver-related deaths, liver disease remains one of the m...
Cardiovascular and liver disease are main contributors to mortality in people with HIV (PWH). In HIV...
The burden of liver-related morbidity remains high among HIV-infected patients, despite advances in ...
Liver disease is an important cause of morbidity and mortality in people living with HIV (PLWH), of ...
Background: Nonalcoholic hepatic steatosis/non- alcoholic fatty liver disease (NAFLD) is rapidly bec...
Introduction. Chronic liver disease (CLD) is becoming a major cause of mortality in patients who are...
ObjectivesHuman immunodeficiency virus (HIV) infection and antiretroviral therapy (ART) may increase...
BACKGROUND AND AIMS: To promote our understanding of the relative contribution of metabolic and vira...
Background and Aims. To promote our understanding of the relative contribution of metabolic and vira...